QuidelOrtho Corp - QDEL Net earnings per share for the last four quarters

Official company branding of Quidel Corporation (QDEL)

Risks of declining demand for COVID tests have been mitigated, yet equipment integration and regulatory pressure on margins remain relevant. Process optimization is based on the outsourcing of logistics and component manufacturing. Annual EPS growth according to financial statements (TTM) demonstrates profit dynamics, where the current level is around 68.50. QuidelOrtho (QDEL) leads in rapid diagnostics, supplying cardiac marker and influenza tests to clinics and pharmacies.

QDEL QuidelOrtho: Earnings per share for the last twelve months in the range 02/11/2024 - 11/15/2026

quidel.com - analytical breakdowns and key metrics (QDEL)

Fundamental company valuation:QuidelOrtho Corporation, QDEL
Mass-produced product of QuidelOrtho

Year-over-year EPS growth (TTM) measures the percentage change in net income per share over a rolling twelve-month period, reflecting the actual efficiency of capital generation. By analyzing annual EPS growth based on financial statements (TTM), an investor separates the systemic resilience of QuidelOrtho (QDEL) from market noise, assessing how costs for the environmental modernization of packaging and equipment impact the business's bottom-line profitability.

Competitor analysis for QuidelOrtho

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)